GOLDEN ARTHUR F
SEC insider (Form 3/4/5 filer). CIK 0001023260. Director at Turn Therapeutics Inc. (TTRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in WESTLAKE VILLAGE, CA.
Companies GOLDEN ARTHUR F has filed insider reports for
- Turn Therapeutics Inc. (TTRX): Director
GOLDEN ARTHUR F
CIK: 0001023260
Transaction Breakdown
Open Market Buys (P)3 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (16.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TTRX
Turn Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 4, 2026TTRX
Turn Therapeutics Inc.
AwardDirectStock option (right to buy)
89.6K shares- - Apr 2, 2026TTRX
Turn Therapeutics Inc.
GiftDirect300K shares- - Nov 24, 2025TTRX
Turn Therapeutics Inc.
PurchaseDirect9.9K shares at avg. $3.44$34K - Nov 21, 2025TTRX
Turn Therapeutics Inc.
PurchaseDirect20.5K shares at avg. $2.87$59K - Oct 23, 2025TTRX
Turn Therapeutics Inc.
PurchaseDirect20.2K shares at avg. $4.95$100K - Oct 8, 2025TTRX
Turn Therapeutics Inc.
AwardDirect10K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 | TTRX Turn Therapeutics Inc. | Award Stock option (right to buy) | 89,584 | - | - | Direct |
| Apr 2, 2026 | TTRX Turn Therapeutics Inc. | Gift | 300,000 | - | $0 | Direct |
| Nov 24, 2025 | TTRX Turn Therapeutics Inc. | Purchase | 9,868 | $3.44 | $33,946 | Direct |
| Nov 21, 2025 | TTRX Turn Therapeutics Inc. | Purchase | 20,532 | $2.87 | $58,927 | Direct |
| Oct 23, 2025 | TTRX Turn Therapeutics Inc. | Purchase | 20,202 | $4.95 | $100,000 | Direct |
| Oct 8, 2025 | TTRX Turn Therapeutics Inc. | Award | 10,000 | - | - | Direct |
1-6 of 6 transactions